Only the HBL melanoma line demonstrated a detectable cyclic adenosine monophosphate (cAMP) response to α-MSH, although all three lines responded to acute α-MSH addition (+(−)-N6-(2-phenylisopropyl)-adenosine (PIA)) with an elevation in intracellular calcium. The gene discussed is STAMBP; the disease is melanoma.